Work

Nintedanib for patients with lymphangioleiomyomatosis: a phase 2, open-label, single-arm study

Year: 2024

Type: article

Study design: Clinical Trial

Source: The Lancet Respiratory Medicine

DOI: 10.1016/s2213-2600(24)00217-0

Authors: Sergio Harari, Davide Elia, Antonella Caminati, Jens Geginat, Francesca Luisi, Giuseppe Pelosi, Claudia Specchia, Olga Torre, Roberta Trevisan, Chiara Vasco, Maurizio Zompatori, Roberto Cassandro

Institutions: University of Milan, MultiMedica, Istituto Nazionale Genetica Molecolare, Fondazione Romeo ed Enrica Invernizzi, University of Brescia

Language: English

Topic: Tuberous Sclerosis Complex Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Boehringer Ingelheim, Boehringer Ingelheim

OpenAlex ID: W4403789303

FWCI: 4.482

Cites: 20

Cited by: 12

Related to: 10